Sign in

Drug to help alcoholics stay sober: study

Updated on: Feb 26, 2009, 10:08:01 IST
PTI | By , Washington
Share
Share via
  • facebook
  • twitter
  • linkedin
  • whatsapp
Copy link
  • copy link
HT Image
HT Image

Scientists are on track to find a more effective treatment for alcoholism, with the discovery that a hormone disorder drug could help drinkers stay sober.

Scientists are on track to find a more effective treatment for alcoholism, with the discovery that a hormone disorder drug could help drinkers stay sober.

According to researchers at the University of California - San Francisco-affiliated Ernest Gallo Clinic and Research Center, a drug prescribed for male and female infertility and menstrual disorders could hold the key to getting rid of the problem.

The study, reported in the journal Biological Psychiatry, showed that "alcoholic" rodents, when injected with the drug cabergoline, decreased their alcohol consumption and alcohol-seeking behavior and were less likely to relapse.

“This is encouraging,” said Dorit Ron, who led the study in the United States.

“It demonstrates that cabergoline is specific for alcohol, but does not affect general reward or pleasure. One of the problems with some existing drugs to treat alcoholism is a side effect that decreases pleasure, making compliance an obstacle to sobriety," underlined Ron, a principal investigator at the Gallo Center and associate professor of neurology at UCSF.

“We show that in mice and rats, a low dose of the drug is enough to reduce excessive alcohol consumption, alcohol seeking and relapse. The dose is similar to what is given to humans for the treatment of hyperprolactinemia,” he was quoted as saying by the Science Daily online.

Catch every big hit, every wicket with Crick-it, a one stop destination for Live Scores, Match Stats, Quizzes, Polls & much more. Explore now!.

Catch your daily dose of Fashion, Taylor Swift, Health, Festivals, Travel, Relationship, Recipe and all the other Latest Lifestyle News on Hindustan Times Website and APPs.